Definitive N-Terminal Protein Sequence and Further Characterization of the Novel Apolipoprotein A5 in Human Serum
| Autor: | Melvin J. Prince, Melvin G. Johnson, William E. Alborn, Robert J. Konrad |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
Serum
Very low-density lipoprotein Apolipoprotein B biology Immunoprecipitation LRP1B Molecular Sequence Data Biochemistry (medical) Clinical Biochemistry Molecular biology Lipoprotein particle Apolipoproteins Biochemistry Apolipoprotein A-V Mutation biology.protein Humans lipids (amino acids peptides and proteins) Amino Acid Sequence Peptide sequence Apolipoproteins A Chylomicron Lipoprotein |
| Zdroj: | Clinical Chemistry. 52:514-517 |
| ISSN: | 1530-8561 0009-9147 |
| DOI: | 10.1373/clinchem.2005.061374 |
| Popis: | Background: Apolipoprotein A5 (ApoA5) originally gained attention as a regulator of serum triglyceride concentrations through transgenic mouse studies. Our group recently developed the first assay to quantify serum ApoA5 protein concentrations and demonstrated that they are increased by administration of a potent peroxisome proliferator-activated receptor-α agonist. Methods: To better characterize the circulating ApoA5, the protein was purified from human serum, and a definitive N-terminal protein sequence was obtained. In light of previous observations that ApoA5 was present in VLDL and not LDL, plasma infranatant and intermediate-density lipoprotein (IDL) were analyzed for ApoA5. Because the mature protein contains a single unpaired cysteine, ApoA5 in human serum was immunoprecipitated, and its migration pattern was examined via Western blotting under reducing and nonreducing conditions to determine whether the protein circulates as a disulfide-linked homodimer or heterodimer. Results: Definitive N-terminal protein sequences obtained from ApoA5 purified from human serum indicated that cleavage of the signal peptide occurs in vivo at the predicted site. We found ApoA5 in VLDL, HDL, and chylomicrons but not in LDL, IDL, or plasma infranatant. Under both reducing and nonreducing conditions, ApoA5 migrated mainly as a single band with a relative molecular mass (Mr) of ∼39 000, indicating that the protein exists in serum as a monomer and not as a disulfide-linked homodimer or heterodimer. Conclusions: Our data help characterize ApoA5 by defining its lipoprotein particle distribution, by determining its N-terminal protein sequence, and by demonstrating that the mature protein circulates mainly as a monomer and not as a disulfide-linked homodimer or heterodimer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|